APA (7th ed.) Citation

Montez-Rath, M. E., Lubwama, R., Kapphahn, K., Ling, A. Y., LoCasale, R., Robinson, L., . . . Desai, M. (2022). Characterizing real world safety profile of oral Janus kinase inhibitors among adult atopic dermatitis patients: Evidence transporting from the rheumatoid arthritis population. Current Medical Research & Opinion, 38(8), 1431. https://doi.org/10.1080/03007995.2022.2088715

Chicago Style (17th ed.) Citation

Montez-Rath, Maria E., Robert Lubwama, Kris Kapphahn, Albee Y. Ling, Robert LoCasale, Lacey Robinson, Karen J. Chandross, and Manisha Desai. "Characterizing Real World Safety Profile of Oral Janus Kinase Inhibitors Among Adult Atopic Dermatitis Patients: Evidence Transporting from the Rheumatoid Arthritis Population." Current Medical Research & Opinion 38, no. 8 (2022): 1431. https://doi.org/10.1080/03007995.2022.2088715.

MLA (9th ed.) Citation

Montez-Rath, Maria E., et al. "Characterizing Real World Safety Profile of Oral Janus Kinase Inhibitors Among Adult Atopic Dermatitis Patients: Evidence Transporting from the Rheumatoid Arthritis Population." Current Medical Research & Opinion, vol. 38, no. 8, 2022, p. 1431, https://doi.org/10.1080/03007995.2022.2088715.